Skip to main content

Table 1 General data between these two groups of patients

From: LY86 facilitates ox-LDL-induced lipid accumulation in macrophages by upregulating SREBP2/HMGCR expression

Variables

AS(n = 67)

Non-AS(n = 20)a

P-value

Age, year

65.2 ± 8.5

61.4 ± 5.7

0.067

Men

54

6

0.314

BMI, kg/m²

25.9 ± 2.9

25.3 ± 3.4

0.427

Co-morbidities, n

   

Hypertension

46

10

0.126

Diabetes mellitus

17

4

0.622

Coronary heart disease

Ischemic stroke

17

3

0.333

18

1

0.061

Risk factors, n

   

Smoking

18

4

0.535

Hyperhomocysteinemia

4

1

0.385

  1. a There were no significant differences between groups